Stoke Therapeutics's total assets for Q2 2025 were $384.51M, a decrease of -5.50% from the previous quarter. STOK total liabilities were $49.56M for the fiscal quarter, a -12.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.